Dr. Yulanka Stephany Castro-Dominguez, MD

Dr. Castro-Dominguez practices at University Hospitals St. John Medical Center in Westlake, Ohio, part of University Hospitals Health System.

Dr. Castro-Dominguez's NPI, 1629404223, was assigned on September 16, 2013. Dr. Castro-Dominguez holds Ohio license 35.142149.

Dr. Castro-Dominguez's primary practice is University Hospitals St. John Medical Center, at 29000 Center Ridge Road, Westlake, OH 44145 in Cuyahoga County. The practice phone is (440) 835-8000.

Dr. Castro-Dominguez's primary practice is University Hospitals St. John Medical Center in Westlake, Ohio, part of University Hospitals Health System. Dr. Castro-Dominguez is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is University Eyecare. Dmand AI also links Dr. Castro-Dominguez to 3 more hospitals, 2 hospital outpatient departments and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Castro-Dominguez practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Castro-Dominguez's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Castro-Dominguez is licensed in Ohio.

CMS data shows 1,382 Medicare services from Dr. Castro-Dominguez across 24 procedure codes in 2024, for 862 Medicare patients. Medicare paid $80,972 for them.

CMS counts 862 Medicare patients who saw Dr. Castro-Dominguez in 2024. The largest group is 75 to 84, with 348 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Castro-Dominguez's median patient age at 73, with 47% women.

In 2024, Dr. Castro-Dominguez wrote 932 Medicare Part D claims for 252 patients. 82% of them were for generic drugs. CMS names the drug for 875 of them, across 20 drugs with 11 or more claims each, at $210,022 in total drug cost. In 2023, CMS named 763 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Castro-Dominguez for performance year 2024, reported through an alternative payment model (APM). Dr. Castro-Dominguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of leg revascularization (restoring blood flow) by Dr. Castro-Dominguez, more than 64% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Castro-Dominguez, published from 2015 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Peripheral Arterial Disease, Femoral Artery and Angioplasty, Balloon. Dr. Castro-Dominguez has published most often in Vasc Med. Dr. Castro-Dominguez's most frequent co-authors are Carlos I. Mena-Hurtado, MD, Mehdi H. Shishehbor, DO and Edouard Aboian, MD.

CMS Open Payments shows 263 general payments to Dr. Castro-Dominguez from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $40,824.